WHO Investment Round Culminates at G20 Summit, Securing Vital Support for Global Health
The World Health Organization’s (WHO) first ever Investment Round reached a high watermark today at the G20 Leaders’ Summit here
Researchers find Improvement in Uric Acid Levels, Gout Symptoms through Plant-based diet
According to a pilot study, a plant-based diet with Mediterranean influences decreased uric acid levels and self-reported gout measurements. According
Experimental Cholesterol Pill of Eli Lilly Shows Promise in Mid-stage Trial
In a recently conducted mid-stage trial, the experimental cholesterol pill by Eli Lilly, muvalaplin, presented promising results, positioning the pharmaceutical
Chikungunya Vaccine Provided to travellers in Alberta Health Centers
When one mosquito bite somewhere sunny could ruin a decade, a new vaccine could save the day. As of this
UK scientists Investigates Whether Resveratrol has the Ability to Prevent Bowel Cancer
Bowel cancer – responsible for most of all cancer deaths in Europe – has been targeted by researchers at the
Yale opens a Partners in Health Engage Chapter
In collaboration with Dwight Hall, Lilia Potter-Schwartz led the establishment of the newest chapter of Partners in Health Engage, an
“I Wish I Could Tell You,” Stated the USFDA Chief When Asked ‘When the Country’s Opioid Crisis Might be Resolved?’
The opioid crisis in the United States, described as the leading cause of death for those aged 18 to 45,
Enhancing the Pregnancy and Delivery Experience for Women
A recent special series of five papers published in the journal PLOS Global Public Health explores strategies to end the
A Late-Stage Study on Eli Lilly’s Crohn’s Disease Drug is Successful
Eli Lilly has reported positive results for its experimental drug mirikizumab in a late-stage study for the treatment of moderately
